Yüklüyor......

Product review on the Anti-PD-L1 antibody atezolizumab

Immunotherapy as a therapeutic strategy has seized the narrative throughout clinical oncology over the past few years. Once considered a niche treatment for rare cancers, immunotherapy has quickly emerged as the standard of care for many common cancer types. The remarkable rise is largely due to the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Shah, Neil J., Kelly, William J., Liu, Stephen V., Choquette, Karin, Spira, Alexander
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5806639/
https://ncbi.nlm.nih.gov/pubmed/29194007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1403694
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!